References
- Arthur SJ, John B. 1978. A colour atlas of histopathological staining techniques. London: Wolfe Med. Pub. Ltd. p. 14–20.
- Aysun H, Burcu B. 2018. An overview of melatonin as an antioxidant molecule: a biochemical approach. in melatonin - molecular biology, clinical and pharmaceutical approaches, Vol. II. London (UK): InTech Open. p. 59–85. doi:https://doi.org/10.5772/57353.
- Beauchamp D, Labrecque G. 2007 Aug 31. Chronobiology and chronotoxicology of antibiotics and aminoglycosides. J Adv Drug Deliv Rev. 59(9–10):896–903. doi:https://doi.org/10.1016/j.addr.2006.07.028. Epub 2007 Jul 4. PMID: 17659809.
- Blunston MA, Yonovitz A, Woodahl EL, Smolensky MH. 2015. Gentamicin-induced ototoxicity and nephrotoxicity vary with circadian time of treatment and entail separate mechanisms. Chronob Int. 32(9):1223–1232. Epub 2015 Oct 27. PMID: 26506922; PMCID: PMC5013539. https://doi.org/https://doi.org/10.3109/07420528.2015.1082483
- Buhr ED, Takahashi JS. 2013. Molecular components of the mammalian circadian clock. Handbook Exp Pharm. 217(217):3–27. doi:https://doi.org/10.1007/978-3-642-25950-0-1.
- Carroll LM, Gaballa A, Guldimann C, Sullivan G, Henderson LO, Wiedmann M. 2019. Enterica serotype typhimurium isolate. mBio. 10(3):1–6. doi:https://doi.org/10.1128/mBio.00853-19.
- Ceylan B, Ozansoy M, Kılıç Ü, Yozgat Y, Ercan Ç, Yıldız P, Aslan T. 2018. N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions. Ren Fail. 40(1):423–434. doi:https://doi.org/10.1080/0886022X.2018.1489286.
- Dai C, Li J, Tang S, Li J, Xiao X. 2014. Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother. 58(7):4075–4085.
- Durrington HJ, Farrow SN, Loudon AS, Ray DW. 2014. The circadian clock and asthma. Thorax. 69(1):90–92. doi:https://doi.org/10.1136/thoraxjnl-2013-203482.
- Eadon MT, Hack BK, Alexander JJ, Xu C, Dolan ME, Cunningham PN. 2013. Cell cycle arrest in a model of colistin nephrotoxicity. Physiol Genomics. 45(19):877–888. https://doi.org/10.1152/physiolgenomics.00076.2013.
- Falagas ME, Kasiakou SK. 2006. Toxicity of polymyxins: A systematic review of the evidence from old and recent studies. Crit Care. doi:https://doi.org/10.1186/cc3995
- Falagas ME, Kasiakou SK, Saravolatz LD. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 40(9):1333–1341. doi:https://doi.org/10.1086/599226.
- Falagas ME, Rafailidis PI. 2009. Nephrotoxicity of colistin: new insight into an old antibiotic. Clin Infect Dis. 48(12):1729–1731. doi:https://doi.org/10.1186/cc3995.
- Firsov D, Bonny O. 2010. Circadian regulation of renal function. Kidney Int. 78(7):640–645. doi:https://doi.org/10.1038/ki.2010.227.
- Gai Z, Samodelov SL, Kullak-Ublick GA, Visentin M. 2019. Molecular mechanisms of colistin-induced nephrotoxicity. Molecules (Basel, Switzerland), 24 (3). 24(3):653. doi:https://doi.org/10.3390/molecules24030653.
- Ghlissi Z, Hakim A, Mnif H, Ayadi FM, Zeghal K, Rebai T, Sahnoun Z. 2013. Evaluation of colistin nephrotoxicity administered at different doses in the rat model. Ren Fail. 35(8):1130–1135. doi:https://doi.org/10.3109/0886022X.2013.815091.
- Ghlissi Z, Hakim A, Mnif H, Zeghal K, Rebai T 2015. Evaluation of the protective effect of vitamins e and c on acute tubular damage induced by colistin in rat model. AJPCT. http://www.imedpub.com/articles/evaluation-of-the-protective-effect-ofvitamins-e-and-c-on-acute-tubular-damageinduced-by-colistin-in-rat-model.pdf.
- Giacometti A. 2002. Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock. J Antimicrob Chemother. 49(1):193–196. doi:https://doi.org/10.1093/jac/49.1.193.
- Gibson GA, Bauer SR, Neuner EA, Bass SN, Lam SW. 2016. Influence of colistin dose on global cure in patients with bacteremia due to carbapenem-resistant gram-negative bacilli. Antimicrob Agents Chemother. 60(1):431–436. doi:https://doi.org/10.1128/AAC.01414-15.
- Hawkey PM, Warren RE, Livermore DM, McNulty CAM, Enoch DA, Otter JA, Wilson APR. 2018. Treatment of infections caused by multidrug-resistant gram-negative bacteria: report of the British society for antimicrobial chemotherapy/healthcare infection society/british infection association joint working party. J Anti Chem. 73(March 2015):iii2–iii78. doi:https://doi.org/10.1093/jac/dky027.
- Hosohata K. 2016. Role of oxidative stress in drug-induced kidney injury. Int J Mol Sci. 17(11):11. doi:https://doi.org/10.3390/ijms17111826.
- Ichikawa I, Kiyama S, Yoshioka T. 1994. Renal antioxidant enzymes: their regulation and function. Kidney Int. 45(1):1–9. doi:https://doi.org/10.1038/ki.1994.1.
- Ighodaro OM, Akinloye OA. 2018. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alex J Med. 54(4):287–293. doi:https://doi.org/10.1016/j.ajme.2017.09.001.
- Jain N, Manish G, Agarwal A, Robo R, Consil S, Kumar S. 2014. Oxidative stress determined through the levels of antioxidant enzymes and the effect of N-acetylcysteine in aluminum phosphide poisoning. Ind J Crit Care Med. 18(10):666–671. doi:https://doi.org/10.4103/0972-5229.142176.
- Jorgenson TC, Zhong W, Oberley TD. 2013. Redox imbalance and biochemical changes in cancer. Cancer Res. 73(20):6118–6123. https://doi.org/https://doi.org/10.1158/0008-5472.CAN–13–1117
- LeBrun M, Grenier L, Gourde P, Bergeron MG, Labrecque G, Beauchamp D. 1999. Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration. Antimicrob Agents Chemother. 43(5):1020–1026. doi:https://doi.org/10.1128/AAC.43.5.1020
- Lévi F, Okyar A, Dulong S, Innominato PF, Clairambault J. 2010. Circadian Timing in Cancer Treatments. Annu Rev Pharmacol Toxicol. 50(1):377–421. doi:https://doi.org/10.1146/annurev.pharmtox.48.113006.094626.
- Lim LM, Ly N, Anderson D, Yang JC, Macander L, Iii AJ, Tsuji BT. 2015. Resurgence of colistin: A review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherpy. 30(12):1279–1291. doi:https://doi.org/10.1592/phco.30.12.1279.Resurgence.
- McKinney W, Yonovitz A, Smolensky MH. 2015 Jul. Circadian variation of gentamicin toxicity in rats. Laryngoscope. 125(7):E252–6. doi:https://doi.org/10.1002/lary.25116. Epub 2015 Feb 3. PMID: 25647042.
- Ozkan G, Ulusoy S, Orem A, Alkanat M, Mungan S, Yulug E, Yucesan FB. 2013. How does colistin-induced nephropathy develop and can it be treated? Antimicrob Agents Chemother. 57(8):3463–3469. doi:https://doi.org/10.1128/AAC.00343-13.
- Paganelli R, Petrarca C, Di Gioacchino M. 2018. Biological clocks: their relevance to immune-allergic diseases. Clin Mol Allergy. 16(1):1–8. doi:https://doi.org/10.1186/s12948-018-0080-0.
- Pfeifer U, Scheller H, Germany W. 1975. A morphometric study of cellular autophagy including diurnal variations in kidney tubules of normal rats. J Cell Biol. 64(3):608–621. doi:https://doi.org/10.1083/jcb.64.3.608
- Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, Kaye KS. 2011. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 53(9):879–884. doi:https://doi.org/10.1093/cid/cir611.
- Portaluppi F, Smolensky MH, Touitou Y. 2010. Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27(9–10):1911–1929.
- Prayle AP, Jain K, Touw DJ, Koch BCP, Knox AJ, Watson A, Smyth AR. 2016. The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison. J Cyst Fibros. 15(4):510–517. doi:https://doi.org/10.1016/j.jcf.2015.07.012.
- Reinberg A, Smolensky MH. 1983. Investigative methodology for chronobiology. In: Reinberg A, Smolensky MH, editors. Investigative methodology for chronobiology. New York: Springer-Verlag; p. 24–46.
- Rougier F, Claude D, Maurin M, Sedoglavic A, Ducher M, Corvaisier S, Maire P. 2003. Aminoglycoside nephrotoxicity: modelling, simulation, and control. Antimicrob Agents Chemother. 47(3):1010–1016. doi:https://doi.org/10.1128/AAC.47.3.1010-1016.2003.
- Sivanesan SS, Schneider EK, Ahmed MU, Huang J, Wang J, Nation RL, Li J. 2017. Gelofusine ameliorates colistin-induced nephrotoxicity. Antimicrob Agents Chemother. doi:https://doi.org/10.1128/AAC.00985-17
- Smolensky MH, Siegel RA, Haus E, Hermida R, Portaluppi F. 2012. Biological rhythms, drug delivery, and chronotherapeutics. In: Fundamentals and applications of controlled release drug delivery. Springer US. p. 359–443. https://doi.org/https://doi.org/10.1007/978-1-4614-0881-9_13
- Soulban G, Smolensky MH, Yonovitz A. 1990. Gentamicin-induced chronotoxicity: use of body temperature as a circadian marker rhythm. Chronobiol Int. 7(5–6):393–402. doi:https://doi.org/10.3109/07420529009059150. PMID: 2097072.
- Spapen H, Jacobs R, Van Gorp V, Troubleyn J, Honoré PM. 2011. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care. 1(1):14. doi:https://doi.org/10.1186/2110-5820-1-14.
- Sulthana N, Sultana A, Madhavi BB. 2015. The clock which times us- chronobiology, chronopharmacology and chronotherapeutics – next frontier in optimizing drug therapy. World J Pharm Pharm Sci. 4(12):400–419.
- Talih G, Esmaoğlu A, Bayram A, Yazici C, Deniz K, Talih T. 2018. Does dexmedetomidine prevent colistin nephrotoxicity? Rev Bras Anestesiol. 68(4):383–387. doi:https://doi.org/10.1016/j.bjan.2018.01.017.
- Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL. 2008. Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. Antimicrob Agents Chemother. 52(9):3047–3051. doi:https://doi.org/10.1128/AAC.00103-08.
- Yamanobe T, Okada F, Iuchi Y, Onuma K, Tomita Y, Fujii J. 2007. Deterioration of ischemia/reperfusion-induced acute renal failure in SOD1-deficient mice. Free Radic Res. 41(2):200–207. doi:https://doi.org/10.1080/10715760601038791.
- Yoshiyama Y, Kobayashi T, Tomonaga F, Nakano S. 1992. Chronotoxical study of gentamicin induced nephrotoxicity in rats. J Antibiot (Tokyo). 45(5):806–808. doi:https://doi.org/10.7164/antibiotics.45.806. PMID: 1624385.
- Yousef JM, Chen G, Hill PA, Nation RL, Li J. 2012. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J Antimicrob Chemother. 67(2):452–459. doi:https://doi.org/10.1093/jac/dkr483.
- Zavascki AP, Nation RL. 2017. Nephrotoxicity of Polymyxins: is there any difference between colistimethate and polymyxin B? Antimicrob Agents Chemother. 61(3):1–10. doi:https://doi.org/10.1128/aac.02319-16.